Accuray (ARAY) Competitors

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Does the media favor ARAY or OFIX?

In the previous week, Orthofix Medical had 4 more articles in the media than Accuray. MarketBeat recorded 5 mentions for Orthofix Medical and 1 mentions for Accuray. Accuray's average media sentiment score of 0.84 beat Orthofix Medical's score of 0.32 indicating that Accuray is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accuray	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals have more ownership in ARAY or OFIX?

64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is ARAY or OFIX more profitable?

Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accuray	-0.96%	-9.75%	-0.93%
Orthofix Medical	-15.18%	-21.25%	-13.29%

Do analysts recommend ARAY or OFIX?

Orthofix Medical has a consensus price target of $23.33, suggesting a potential upside of 67.26%. Given Orthofix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Orthofix Medical is more favorable than Accuray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accuray	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Orthofix Medical	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has higher earnings & valuation, ARAY or OFIX?

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accuray	$453.14M	0.35	-$15.55M	-$0.05	-30.80
Orthofix Medical	$799.49M	0.68	-$151.40M	-$3.29	-4.24

Which has more volatility and risk, ARAY or OFIX?

Accuray has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Does the MarketBeat Community believe in ARAY or OFIX?

Orthofix Medical received 82 more outperform votes than Accuray when rated by MarketBeat users. However, 65.63% of users gave Accuray an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
Accuray	Outperform Votes 336 65.63%	Underperform Votes 176 34.38%
Orthofix Medical	Outperform Votes 418 62.20%	Underperform Votes 254 37.80%

Summary

Accuray and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks.